Higher tumor protein kinase D1 correlates with increased tumor size, BCLC stage, CA199 level, AFP level and worse overall survival in hepatocellular carcinoma patients
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 45 (6) , 101573
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular CarcinomaCancer Research, 2018
- PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancerOncotarget, 2018
- Hepatocellular carcinomaThe Lancet, 2018
- Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2017
- Protein kinase D signaling in cancer: A friend or foe?Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2017
- Protein kinase D1 mRNA level may predict cancer-specific survival in heavy smokers with esophageal squamous cell cancersDiseases of the Esophagus, 2013
- The role of PKC isoforms in the inhibition of NF-κB activation by vitamin K2 in human hepatocellular carcinoma cellsThe Journal of Nutritional Biochemistry, 2012
- Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathwayExperimental Cell Research, 2012
- Role of protein kinase D signaling in pancreatic cancerBiochemical Pharmacology, 2010
- Protein kinase D1 promotes anchorage‐independent growth, invasion, and angiogenesis by human pancreatic cancer cellsJournal of Cellular Physiology, 2010